Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, Bico Group, Cellink Bioprinting, Geistlich Pharma, Gemini Bioproducts, Guardant Health, Natera, Stimlabs.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Zimmer Biomet.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alpheus Medical, Boston Scientific, Caris, Soundhealth, Stanford University.

Med-tech firms raising money in public or private financings, including: Autonomix, Cradle, Eyenovia, Neoplas.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascentage, Brii.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Alpha Biopharma, Astellas, Inxmed, Junshi, Leads Biolabs, Ractigen, Samsung Bioepis.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Avenzo, Beigene, Bristol Meyers Squibb, HCW Biologics, Intas, SK Biopharmaceuticals, Telix, Velavigo, WY Biotech, Xbrane.

New hires and promotions in biopharma in Asia-Pacific, including: Alterity, Hutchmed.

Biopharmas in Asia-Pacific raising money in public or private financings: C-Ray Therapeutics.

BioWorld Asia briefs for November 26, 2024.